JiangXi Tianxin Pharmaceutical Co., Ltd. (SHA:603235)
26.88
-0.51 (-1.86%)
At close: Mar 9, 2026
SHA:603235 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2018 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 6, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2018 |
| Market Capitalization | 11,697 | 11,145 | 10,524 | 12,748 | - | - | Upgrade
|
| Market Cap Growth | 2.15% | 5.90% | -17.45% | - | - | - | Upgrade
|
| Enterprise Value | 10,544 | 9,508 | 8,230 | 10,499 | - | - | Upgrade
|
| Last Close Price | 26.88 | 24.94 | 22.99 | 27.17 | - | - | Upgrade
|
| PE Ratio | 18.93 | 17.11 | 22.12 | 20.49 | - | - | Upgrade
|
| PS Ratio | 5.26 | 5.05 | 5.59 | 5.53 | - | - | Upgrade
|
| PB Ratio | 2.44 | 2.42 | 2.49 | 3.14 | - | - | Upgrade
|
| P/TBV Ratio | 2.55 | 2.52 | 2.61 | 3.23 | - | - | Upgrade
|
| P/FCF Ratio | - | - | 54.36 | 36.83 | - | - | Upgrade
|
| P/OCF Ratio | 21.25 | 22.31 | 14.43 | 21.02 | - | - | Upgrade
|
| EV/Sales Ratio | 4.74 | 4.31 | 4.37 | 4.56 | - | - | Upgrade
|
| EV/EBITDA Ratio | 12.96 | 12.35 | 15.11 | 15.09 | - | - | Upgrade
|
| EV/EBIT Ratio | 16.27 | 15.36 | 20.13 | 18.35 | - | - | Upgrade
|
| EV/FCF Ratio | -44.84 | - | 42.51 | 30.33 | - | - | Upgrade
|
| Debt / Equity Ratio | 0.08 | 0.03 | 0.03 | 0.00 | 0.18 | 0.30 | Upgrade
|
| Debt / EBITDA Ratio | 0.46 | 0.19 | 0.20 | 0.01 | 0.36 | 0.30 | Upgrade
|
| Debt / FCF Ratio | - | - | 0.56 | 0.02 | 0.58 | 0.40 | Upgrade
|
| Net Debt / Equity Ratio | -0.24 | -0.31 | -0.52 | -0.56 | -0.19 | -0.58 | Upgrade
|
| Net Debt / EBITDA Ratio | -1.42 | -1.83 | -4.04 | -3.29 | -0.38 | -0.59 | Upgrade
|
| Net Debt / FCF Ratio | 4.91 | 2.49 | -11.36 | -6.62 | -0.61 | -0.78 | Upgrade
|
| Asset Turnover | 0.40 | 0.41 | 0.39 | 0.60 | 0.86 | 0.83 | Upgrade
|
| Inventory Turnover | 2.39 | 2.41 | 2.47 | 3.31 | 3.89 | 3.53 | Upgrade
|
| Quick Ratio | 3.94 | 3.88 | 5.62 | 8.55 | 1.68 | 0.88 | Upgrade
|
| Current Ratio | 5.48 | 5.29 | 6.77 | 10.18 | 2.33 | 1.11 | Upgrade
|
| Return on Equity (ROE) | 13.35% | 14.72% | 11.48% | 20.85% | 48.56% | 71.64% | Upgrade
|
| Return on Assets (ROA) | 7.23% | 7.24% | 5.23% | 9.37% | 18.39% | 23.47% | Upgrade
|
| Return on Invested Capital (ROIC) | 15.12% | 19.94% | 18.12% | 29.64% | 72.55% | 166.57% | Upgrade
|
| Return on Capital Employed (ROCE) | 11.90% | 12.20% | 8.80% | 13.10% | 37.90% | 73.80% | Upgrade
|
| Earnings Yield | 5.28% | 5.84% | 4.52% | 4.88% | - | - | Upgrade
|
| FCF Yield | -2.01% | -5.09% | 1.84% | 2.71% | - | - | Upgrade
|
| Dividend Yield | 2.48% | 2.73% | 2.17% | 2.61% | - | - | Upgrade
|
| Payout Ratio | 49.00% | 33.81% | 65.66% | 1.10% | 118.09% | 96.20% | Upgrade
|
| Buyback Yield / Dilution | 0.18% | -0.11% | -5.96% | -4.68% | 0.10% | - | Upgrade
|
| Total Shareholder Return | 2.66% | 2.61% | -3.79% | -2.06% | 0.10% | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.